Pharmaceutical composition comprising refined Indigo naturalis extracts and the use thereof
US10555985B2 · kind B2 · utility
2Cited by
5References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 30, 2019 |
| Grant date | Feb 11, 2020 |
| Priority date | — |
| Expiry date | Jan 30, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K2800/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A refined Indigo Naturalis extract or Indigo-producing plant extract containing at least 65% (w/w) an indirubin derivative based on total weight of active ingredients is described. Also described are a pharmaceutical composition containing the refined extract, and the use of the pharmaceutical composition for treating or alleviating a disease or condition.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.